December 19, 2023

Biotalys Announces Results of Independent Field Trials in the U.S.

PDF icon
EN PDF icon
NL
November 29, 2023

Biotalys Provides Company Update

PDF icon
EN PDF icon
NL
October 5, 2023

Kevin Helash commences role as Chief Executive Officer of Biotalys

PDF icon
EN PDF icon
NL
October 2, 2023

Biotalys announces the appointment of Kevin Helash as Chief Executive Officer and Director to lead the company in its next growth phase

PDF icon
EN PDF icon
NL
September 26, 2023

Biotalys announces participation at upcoming scientific, industry and investor events

PDF icon
EN PDF icon
NL
August 23, 2023

Biotalys Reports Half-Year 2023 Financial Results and Business Highlights

PDF icon
EN PDF icon
NL
July 20, 2023

Invitation to a Special Shareholders’ Meeting

PDF icon
EN PDF icon
NL
July 5, 2023

Publication of transparency notification

PDF icon
EN PDF icon
NL
June 12, 2023

Biotalys announces closing of private placement

PDF icon
EN PDF icon
NL
June 7, 2023

Biotalys Strengthens Relationship with Investors via Private Placement of New Shares for €7 million

PDF icon
EN PDF icon
NL
May 31, 2023

Biotalys Continues to Demonstrate Strength of First Biocontrol in Latest Global Field Trials

PDF icon
EN PDF icon
NL
April 25, 2023

Results of the Annual and Extraordinary Shareholders’ Meeting

PDF icon
EN PDF icon
NL
April 24, 2023

Syngenta and Biotalys enter into strategic partnership in biologicals innovation to advance solutions for sustainable agriculture

PDF icon
EN PDF icon
NL
March 24, 2023

Invitation to the Annual and an Extraordinary Shareholders Meeting

PDF icon
EN PDF icon
NL
March 14, 2023

Biotalys announces Chief Financial Officer succession plan

PDF icon
EN PDF icon
NL